Cytori Announces Presentations at Biotech Showcase on Jan 9th and 10th
SAN DIEGO, CA -- (MARKET WIRE) -- 01/05/12 -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will webcast their corporate presentation at the Biotech Showcase at 4:00 PM PT on Monday, January 9 in San Francisco. The webcast may be accessed under "Webcasts" in the Investor Relations section of the Company's website, www.cytori.com. The webcast can be accessed live and will be available for replay after the presentation on the Company's website.
In addition, Cytori will be participating on the Regenerative Medicine Insight Track. The details are as follows:
Regenerative Medicine Insight Track at the Biotech Showcase
Date: January 10, 2012
Time: 9:30 - 10:45 AM PT
Panel: Therapeutic Focus Panel: Cardiovascular, AMI and PAD
Location: Parc 55 Wyndham, 55 Cyril Magnin Street, San Francisco, CA
About the Regenerative Medicine Insight Track:
This event was developed by the Alliance for Regenerative Medicine, and will be held as part of the Biotech Showcase 2012 conference. The meeting will start with the Second Annual State of the Industry Briefing, followed by a series of analyst-led panels focused on therapeutic areas where regenerative medicine holds great promise. The State of the Industry briefing is open to the public, but attendance at the disease panels will require registration for individuals without press or investor credentials.
Cytori is a leader in cell therapy, providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft® products are available in North America and Europe for fat grafting procedures. www.cytori.com
Contact: Megan McCormick email@example.com +1.858.875.5279
Source: Cytori Therapeutics, Inc.